Patient-centred and fit-for-purpose clinical trials in rare cancers: lessons from sarcomas for operationalising 2024 WHO Guidance and ICH E6(R3)
Ornella Gonzato, Denise K. Reinke, Roger Wilson, Bernd Kasper et autres
0 citationsEClinicalMedicine
Roger Wilson
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
96Publications signalées
1839Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Health Systems, Economic Evaluations, Quality of LifeSarcoma Diagnosis and TreatmentCancer survivorship and careMental Health and Patient InvolvementInnovations in Medical Education
Publications récentes
Optimising patient centred drug development to realise impact
Melanie Calvert, Paul Kamudoni, Christina Yap, C. J. Snyder et autres
0 citationsCommunications Medicine
Factors Associated with Time to Sarcoma Diagnosis: Results from a Global Cross-Sectional Survey by the Sarcoma Patient Advocacy Global Network (SPAGN)
Verena Loidl, Kathrin Schuster, Roger Wilson, Denise K. Reinke et autres
0 citationsCancers
127MO A practical toolkit with recommendations for analysing and visualising patient-reported outcomes in early phase dose-finding oncology trials: OPTIMISE-AR
E.L. Alger, Antoine Regnault, A. Dueck, M. Pe et autres
0 citationsESMO Open
A practical toolkit with recommendations for analysing and visualising patient-reported outcomes in early phase dose-finding oncology trials (OPTIMISE-AR)
Emily Alger, Antoine Regnault, Amylou C Dueck, M. Pe et autres
2 citationsThe Lancet Oncology
2712P Determinants of diagnostic intervals in sarcoma: Results from the global diagnosis pathway survey
V. Loidl, Kathrin Schuster, Denise K. Reinke, Mo Sha et autres
0 citationsAnnals of Oncology
87O International consensus-driven recommendations for patient-reported outcome research objectives in early phase dose-finding oncology clinical trials: OPTIMISE-ROR
Emily Alger, Olalekan Lee Aiyegbusi, Amylou C. Dueck, Anna Minchom et autres
0 citationsESMO Open
Symptoms, side effects, quality of life and financial toxicity matter to patients with cancer, we need to do a better job of capturing and reporting these concepts in trials and clinical care
Melanie Calvert, Roger Wilson, John Devin Peipert
3 citationsBMJ Oncology
Recommendations to promote equity, diversity and inclusion in decentralized clinical trials
Olalekan Lee Aiyegbusi, Samantha Cruz Rivera, Paul Kamudoni, Nicola Anderson et autres
32 citationsNature Medicine
Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials – insights from an expert virtual roundtable
Anna Minchom, Melanie Calvert, Steven Rizk, Philip Collis et autres
0 citationsCarolina Digital Repository (University of North Carolina at Chapel Hill)
Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials – insights from an expert virtual roundtable
Christina Yap, Olalekan Lee Aiyegbusi, Emily Alger, Ethan Basch et autres
23 citationsEClinicalMedicine
Improving completion rates of patient-reported outcome measures in cancer clinical trials: Scoping review investigating the implications for trial designs
Lotte van der Weijst, Abigirl Machingura, Ahu Alanya, Emma Lidington et autres
22 citationsEuropean Journal of Cancer
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.